New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism

被引:309
作者
Eid, Stephanie [1 ]
Sas, Kelli M. [2 ]
Abcouwer, Steven F. [3 ]
Feldman, Eva L. [1 ]
Gardner, Thomas W. [3 ,4 ]
Pennathur, Subramaniam [2 ,4 ]
Fort, Patrice E. [3 ,4 ]
机构
[1] Univ Michigan, Dept Neurol, Ann Arbor, MI USA
[2] Univ Michigan, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, 1000 Wall St, Ann Arbor, MI 48105 USA
[4] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
Diabetes; Diabetic complications; Lipid metabolism; Omics; Review; Specific mechanisms; KIDNEY-DISEASE; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; GLUCOSE CONTROL; OXIDIZED LDL; RISK-FACTORS; KEY ROLE; RETINOPATHY; TYPE-1; PROGRESSION;
D O I
10.1007/s00125-019-4959-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes adversely affects multiple organs, including the kidney, eye and nerve, leading to diabetic kidney disease, diabetic retinopathy and diabetic neuropathy, respectively. In both type 1 and type 2 diabetes, tissue damage is organ specific and is secondary to a combination of multiple metabolic insults. Hyperglycaemia, dyslipidaemia and hypertension combine with the duration and type of diabetes to define the distinct pathophysiology underlying diabetic kidney disease, diabetic retinopathy and diabetic neuropathy. Only recently have the commonalities and differences in the metabolic basis of these tissue-specific complications, particularly those involving local and systemic lipids, been systematically examined. This review focuses on recent progress made using preclinical models and human-based approaches towards understanding how bioenergetics and metabolomic profiles contribute to diabetic kidney disease, diabetic retinopathy and diabetic neuropathy. This new understanding of the biology of complication-prone tissues highlights the need for organ-specific interventions in the treatment of diabetic complications.
引用
收藏
页码:1539 / 1549
页数:11
相关论文
共 115 条
  • [1] Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment
    Abcouwer, Steven F.
    Gardner, Thomas W.
    [J]. YEAR IN DIABETES AND OBESITY, 2014, 1311 : 174 - 190
  • [2] Lipidomics and Biomarker Discovery in Kidney Disease
    Afshinnia, Farsad
    Rajendiran, Thekkelnaycke M.
    Wernisch, Stefanie
    Soni, Tanu
    Jadoon, Adil
    Karnovsky, Alla
    Michailidis, George
    Pennathur, Subramaniam
    [J]. SEMINARS IN NEPHROLOGY, 2018, 38 (02) : 127 - 141
  • [3] Impaired β-Oxidation and Altered Complex Lipid Fatty Acid Partitioning with Advancing CKD
    Afshinnia, Farsad
    Rajendiran, Thekkelnaycke M.
    Soni, Tanu
    Byun, Jaeman
    Wernisch, Stefanie
    Sas, Kelli M.
    Hawkins, Jennifer
    Bellovich, Keith
    Gipson, Debbie
    Michailidis, George
    Pennathur, Subramaniam
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 29 (01): : 295 - 306
  • [4] Lipidomic Signature of Progression of Chronic Kidney Disease in the Chronic Renal Insufficiency Cohort
    Afshinnia, Farsad
    Rajendiran, Thekkelnaycke M.
    Karnovsky, Alla
    Soni, Tanu
    Wang, Xue
    Xie, Dawei
    Yang, Wei
    Shafi, Tariq
    Weir, Matthew R.
    He, Jiang
    Brecklin, Carolyn S.
    Rhee, Eugene P.
    Schelling, Jeffrey R.
    Ojo, Akinlolu
    Feldman, Harold
    Michailidis, George
    Pennathur, Subramaniam
    [J]. KIDNEY INTERNATIONAL REPORTS, 2016, 1 (04): : 256 - 268
  • [5] A mitochondrial therapeutic reverses visual decline in mouse models of diabetes
    Alam, Nazia M.
    Mills, William C.
    Wong, Aimee A.
    Douglas, Robert M.
    Szeto, Hazel H.
    Prusky, Glen T.
    [J]. DISEASE MODELS & MECHANISMS, 2015, 8 (07) : 701 - 710
  • [6] [Anonymous], 2018, WECHATS ANN DATA REP
  • [7] [Anonymous], 2017, DIAB FACTS FIG
  • [8] Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: Results from the Diabetes Atherosclerosis Intervention Study (DAIS)
    Ansquer, JC
    Foucher, C
    Rattier, S
    Taskinen, MR
    Steiner, G
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (03) : 485 - 493
  • [9] Enhanced glucose control for preventing and treating diabetic neuropathy
    Callaghan, B. C.
    Little, A. A.
    Feldman, E. L.
    Hughes, R. A. C.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (06):
  • [10] Diabetes and obesity are the main metabolic drivers of peripheral neuropathy
    Callaghan, Brian C.
    Gao, LeiLi
    Li, Yufeng
    Zhou, Xianghai
    Reynolds, Evan
    Banerjee, Mousumi
    Pop-Busui, Rodica
    Feldman, Eva L.
    Ji, Linong
    [J]. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2018, 5 (04): : 397 - 405